DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Humalog Mix50 / 50 (Insulin Lispro Subcutaneous) - Current Clinical Trials

 
 



Clinical Trials Related to Humalog Mix50/50 (Insulin Lispro Subcutaneous)

Phase II Pharmacokinetics Study of Humalog and Humulin-R With and Without rHuPH20 in Type 1 Diabetes Mellitus [Completed]

Immunogenicity Study of Wockhardt's Insulin Lispro/Lispro Mix Basal Bolus Regimen in Type 1 Diabetics [Withdrawn]

Humalog® Mix50/50(tm) as a Treatment for Gestational Diabetes [Completed]

Insulin Lispro 6 Days Versus Insulin Aspart 6 Days in Pump Use [Completed]

A Study of Insulin Lispro With BioChaperone Excipient in Healthy Participants [Completed]

A Double-blinded, Randomised, Two -Period Crossover Euglycemic Clamp Trial Investigating the Pharmacokinetics, Glucodynamics and Safety of BioChaperone Insulin Lispro and Insulin Lispro (Humalog®) in Subjects With Type 1 Diabetes [Completed]

A Trial to Compare the Pharmacodynamic and Pharmacokinetic Properties of Biochaperone® Combo With Humalog® Mix25 and With Simultaneous Injections of Humalog® and Lantus® in Subjects With Type 2 Diabetes [Recruiting]

Liquid Meal Study With Insulin Lispro With/Without Recombinant Human Hyaluronidase PH20 (rHuPH20) and Regular Human Insulin With rHuPH20 to Compare Pharmacokinetics, Postprandial Glycemic Response, and Optimal Insulin Dose in Participants With Type 2 Diabetes Mellitus (T2DM) [Completed]

Pharmacokinetic (PK), Pharmacodynamic (PD), and Safety Study of Subcutaneously Administered Humalog® With and Without Recombinant Human Hyaluronidase (rHuPH20)and Humulin-R® With and Without rHuPH20 [Completed]

Comparison of SAR342434 to Humalog as the Rapid Acting Insulin in Adult Patients With Type 1 Diabetes Mellitus Also Using Insulin Glargine [Active, not recruiting]

A Study of LY2605541 and Insulin Lispro Mixture in Healthy Participants [Completed]

Blood Glucose Control With BioChaperone Insulin Lispro Compared to Insulin Lispro (Humalog®) After Ingestion of a Standardized Meal [Completed]

To Investigate the Efficacy and Safety of Individualized Doses of BioChaperone Insulin Lispro in Comparison to Humalog® U-100 in Patients With Type 1 Diabetes Mellitus [Recruiting]

Lispro Mid Mixture (MM) Intensive Mixture Therapy With Progressive Dose-Titration of Lispro Low Mixture (LM) or Biphasic Insulin Aspart 30/70 (S019) [Completed]

Lispro Mix 25 vs. Glargine in Type 2 Diabetics [Completed]

Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Patients With Type 2 Diabetes Mellitus [Completed]

A Trial Comparing Two Therapies: Basal Insulin/Glargine, Exenatide and Metformin Therapy (BET) or Basal Insulin/Glargine, Bolus Insulin Lispro and Metformin Therapy (BBT) in Subjects With Type 2 Diabetes [Completed]

A Study of Lispro Formulations in Healthy Participants [Recruiting]

Comparison of SAR342434 to Humalog as the Rapid Acting Insulin in Adult Patients With Type 2 Diabetes Mellitus Also Using Insulin Glargine [Recruiting]

Safety and Efficacy Study of Insulin Lispro Versus Insulin Aspart in Participants With Type 2 Diabetes on Insulin Pump Therapy [Completed]

Lantus Versus Humalog Mix as add-on Therapy in Type Diabetes Patients Failing Sulfonylurea and Metformin Combination Treatment [Completed]

Comparator Trial Using Insulin Glulisine vs. Insulin Lispro for Treatment of Gestational Diabetes [Active, not recruiting]

Efficacy of Insulin Lispro Mix 50/50 Therapy [Recruiting]

A Double-blinded, Randomised, Three-period Crossover Euglycaemic Clamp Trial Investigating the Pharmacokinetics, Glucodynamics and Safety of BioChaperone Human Insulin, Human Insulin (Huminsulin� Normal) and Insulin Lispro (Humalog�) in Subjects With Type 1 Diabetes [Completed]

Comparison of the Efficacy and Safety of Two Insulin Intensification Strategies [Completed]

Pharmacokinetic and Pharmacodynamic Properties of BIOD-123 and BIOD-125 Compared to Humalog® in Subjects With Type 1 Diabetes Including Assessments of Injection Site Toleration [Completed]

Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes Mellitus [Completed]

A Randomized Control Trial Comparing Linjeta Versus Humalog in Pumps: Effect on Postprandial Blood Sugars. [Suspended]

A Double-blinded, Randomised, Four-period Crossover Euglycemic Clamp Trial Investigating the Dose-response and Dose-exposure Relationship of BioChaperone Insulin Lispro in Three Different Doses in Subjects With Type 1 Diabetes [Completed]

Bioequivalence of Two Lispro Formulations [Completed]

Pharmacokinetic and Glucodynamic Crossover Study of Subcutaneously (SC) Administered Insulin Lispro + Recombinant Human Hyaluronidase (rHuPH20) and Regular Human Insulin + rHuPH20 Compared to Insulin Lispro Alone [Completed]

Insulin Lispro 6 Days Versus Insulin Aspart 6 Days in Pump Use [Completed]

A Trial to Assess the Efficacy and Safety of BioChaperone Combo and Humalog Mix 25 in Subjects With Type 1 Diabetes [Completed]

Comparison of Insulins Aspart and Lispro in Insulin Pumps [Completed]

A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog�) [Completed]

Safety and Efficacy of Technosphere® Insulin Inhalation Powder and Lantus® Compared to Humalog® and Lantus® Over 16-Weeks [Terminated]

A Study to Compare Pharmacokinetics and Pharmacodynamics of SAR342434 to Insulin Lispro in Subjects With Type 1 Diabetes [Completed]

A Clinical Trial Investigating the Intra-subject Variability of Pharmacokinetics and Glucodynamics of BioChaperone Insulin Lispro U-100 Product and U-200 Product in Healthy Volunteers [Recruiting]

A Study for Type 2 Diabetic Patients [Completed]

Comparison of Two Basal Insulins for Patients With Type 2 Diabetes on Anti-Hyperglycemic Medications (IOPE) [Completed]

24 Hour Plasma Glucose Profiles Comparing Lispro Mix 75/25 vs. Glargine [Completed]

Study of Insulin Lispro in Participants With Inadequately Controlled Type 2 Diabetes [Completed]

Comparison of Two Basal Insulin Therapies for Patients With Type 1 Diabetes [Completed]

The Management of Glucocorticoid-Induced Hyperglycemia in Hospitalized Patients [Recruiting]

Pharmacokinetic and Pharmacodynamic Profile of Insulin Lispro Using Needle-Free Jet Injection Technology [Recruiting]

A Study to Compare and Measure the Effects of Insulin Peglispro and Glargine on Meal Time Insulin Requirements [Completed]

Comparison of Two Basal Insulins for Patients With Type 2 Diabetes (IOOY) [Completed]

A Study in Participants With Type 1 Diabetes Mellitus [Completed]

Comparison of Two Approaches to Insulin Therapy in Patients With Type 2 Diabetes (IOOX) [Completed]

DPP4 Inhibitor in the Hospital [Completed]

A Study Comparing Insulin Intensification Therapies in Patients With Type 2 Diabetes Mellitus [Completed]

A Study in Adults With Type 1 Diabetes [Completed]

PK/PD Study of Intranasal Insulin in Type I Diabetes [Not yet recruiting]

Comparison of Insulin Mix25 Versus Mix50 [Completed]

Safety and Efficacy Study of Correcting Hyperglycemia in Patients With Diabetes Having Out-patient Surgery [Recruiting]

Safety and Efficacy of Technosphere� Insulin Inhalation Powder (TI Inhalation Powder)When an Optimal Dose is Taken With Varied Carbohydrate Intake [Terminated]

A Study for Patients With Diabetes Mellitus (IOPA) [Completed]

Dose-Ranging, Pharmacokinetic (PK), Glucodynamic (GD), Safety and Tolerability Study of Subcutaneously (SC) Administered Humulin R and Humalog With or Without rHuPH20 [Active, not recruiting]

Effect of Insulin Glulisine Compared to Insulin Aspart and Insulin Lispro When Administered by Continuous Subcutaneous Insulin Infusion (CSII) on Specific Pump Parameters in Patient With Type 1 Diabetes Mellitus [Completed]

Insulin Glulisine, Insulin Lispro and Insulin Glargine in Type 1 or 2 Diabetes Mellitus [Completed]

Hospital Management of Hyperglycemia Study of Insulin Glargine Plus Insulin Lispro Versus Human Regular Insulin [Terminated]

Absorption of Insulin Following Subcutaneous Bolus Administration With Different Bolus Durations [Completed]

A Pharmacokinetic and Glucodynamic Study of Subcutaneously Administered Insulin Analogs With rHuPH20 Compared to Insulin Analogs Alone [Completed]

Safety and Efficacy of NovoLog vs. Humalog in Insulin Pumps in Children and Adolescents [Completed]

Metformin and Sitagliptin Therapy for Adult Patients With Type 2 Diabetes Admitted to the General Medical Unit [Not yet recruiting]

Exubera vs Lispro in a Lantus-based Regimen for Improved Glycemic Control in Type 2 Diabetes [Completed]

A Trial to Compare the PK and PD of Insulin Lispro Administered Into Different Tissues in Subjects With Diabetes Mellitus Type 1 [Completed]

Randomized, Double Blind, 2 Way Crossover Study of CSII With, Versus Without, Pretreatment With Human Hyaluronidase [Completed]

A Study Evaluating the Bioequivalence of VIAject�7 Compared to VIAject�25 and Comparing the Pharmacokinetic and Pharmacodynamic Properties of VIAject�7 to Insulin Lispro in Subjects With Type 1 Diabetes Mellitus [Completed]

Comparison of Two Basal Insulins for Patients With Type 2 Diabetes Taking Oral Diabetes Medicines and Exenatide [Completed]

Feasibility Study of the Effect of Intra-Dermal Insulin Injection on Blood Glucose Levels After Eating [Completed]

Hyperglycemia and Cardiovascular Outcomes With Type 2 Diabetes [Completed]

6-month Comparison of Morning Lantus Versus Neutral Protamine Hagedorn Insulin in Young Children With Type 1 Diabetes [Completed]

Comparing Pre-Mixed Insulin With Insulin Glargine Combined With Rapid-Acting Insulin in Patients With Type 2 Diabetes [Completed]

32 Week, Open, Randomized, 2 Way Cross Over Multicentre Trial to Compare Safety & Efficacy of Combination of HOE901 Insulin Analogue Once Daily at Bedtime + Lispro Insulin Before Meals vs NPH Insulin (Twice a Day) + Regular in Type 1 Diabetes Mellitus [Completed]

Effect of a Fixed Pramlintide: Insulin Dose Ratio on Postprandial Glucose in Type 1 Diabetes Mellitus [Not yet recruiting]

Long-Term Effects of Insulin Plus Metformin Regimens on the Overall and Postprandial Glycemic Control of Patients With Type 2 Diabetes [Completed]

Sitagliptin Therapy in Hospitalized Patients With Type 2 Diabetes [Recruiting]

Compare Blood Sugar Level Between Lantus in the Morning and Other Insulins in Type 1 Diabetes Adolescents [Completed]

Insulin Bolus Required for High Fat Foods in Type 1 Diabetes [Enrolling by invitation]

A Study Comparing Continuous Subcutaneous Insulin Infusion With Multiple Daily Injections With Insulin Lispro and Glargine [Completed]

Linagliptin Inpatient Trial [Recruiting]

Insulin Therapy in the Hospital Comparing Two Protocols [Completed]

A Study of Postprandial Hyperglycemia in Participants With Type 2 Diabetes [Completed]

Efficacy of Pulsatile IV Insulin on Cognition and Amyloid Burden in Patients With Alzheimer's Disease [Withdrawn]

A Study to Characterize Regimens of Basal Insulin Intensified With Either Symlin® or Rapid Acting Insulin in Patients With Type 2 Diabetes [Completed]

Effects of Pulsatile Intravenous Insulin Delivery on Diabetic Neuropathy in pATIENTS (Pts) With Type 1 and Type 2 Diabetes [Terminated]

A Study Comparing Dulaglutide With Insulin Glargine on Glycemic Control in Participants With Type 2 Diabetes (T2D) and Moderate or Severe Chronic Kidney Disease (CKD) [Recruiting]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017